Effects of gender and gonadectomy on responses to chronic benzodiazepine receptor agonist exposure in rats.
Gonadal steroid hormones or their derivatives have been shown to modulate the GABA receptor complex and GABA-mediated responses in a manner similar to the benzodiazepines. The present study examines if hormonal status modulates the development of tolerance and/or the neural adaptations in GABAA receptors associated with chronic benzodiazepine exposure. Anticonvulsant effects of diazepam were compared in groups of male, female, orchidectomized, and ovariectomized rats following acute (3 day) and chronic (3 week) exposure to diazepam-filled silastic implants. Results indicated that hormonal status did not significantly modify either the neural levels of drug resulting from the diazepam implants or the diazepam-induced increases in bicuculline seizure thresholds following acute (3 day) exposure. Unlike males and gonad-intact females, ovariectomized rats continued to display elevated seizure threshold values due to the diazepam released from the implants even after chronic diazepam exposure. This suggests that the tolerance to benzodiazepine actions observed in male and intact female rats was prevented by ovariectomy. Analysis of the anticonvulsant effects of additional challenge doses of diazepam in chronic diazepam-treated rats paradoxically suggested that benzodiazepine tolerance developed in all hormone groups. The discrepancies between these two tests of anticonvulsant tolerance may be related to the divergent neural GABAA receptor adaptations seen between hormone groups. Ovariectomized rats displayed a reduction in GABA IC50 values for [3H]bicuculline-thiocyanate binding in cortex following chronic diazepam exposure that was not observed in males or intact females. These results suggest that the diminution of ovarian steroid hormones may modulate the neural GABAergic changes associated with the development of tolerance to benzodiazepine actions during chronic agonist exposure.
Wilson
M A
MA
Department of Pharmacology, University of South Carolina, School of Medicine, Columbia 29208.
Biscardi
R
R
D000818:Animals; D001569:Benzodiazepines / Q000378:metabolism; D001640:Bicuculline / Q000378:metabolism; D001921:Brain / Q000187:drug effects / Q000378:metabolism; D003975:Diazepam / Q000494:pharmacology; D004343:Drug Implants; D004361:Drug Tolerance; D005260:Female; D006728:Hormones / Q000502:physiology; D008297:Male; D009919:Orchiectomy; D010052:Ovariectomy; D010053:Ovary / Q000502:physiology* / Q000601:surgery; D051381:Rats; D011919:Rats, Inbred Strains; D011963:Receptors, GABA-A / Q000187:drug effects / Q000378:metabolism / Q000502:physiology*; D012737:Sex Factors; D012826:Silicone Elastomers; D013737:Testis / Q000502:physiology* / Q000601:surgery; D013997:Time Factors; D014316:Tritium
D004343:Drug Implants; D006728:Hormones; D011963:Receptors, GABA-A; D012826:Silicone Elastomers; D014316:Tritium; D001569:Benzodiazepines; D003975:Diazepam; D001640:Bicuculline